Free Trial
→ Forget AI Stocks — This Device Will REPLACE the Microchip (From Banyan Hill Publishing) (Ad)tc pixel

Terumo (OTCMKTS:TRUMY) Hits New 52-Week Low - Should You Sell?

Written by MarketBeat
September 25, 2025
Terumo logo with Medical background

Key Points

  • Terumo Corp. (OTCMKTS:TRUMY) hit a new 52-week low on Thursday, trading at $15.95, before closing at $16.07.
  • The company reported earnings per share of $0.20, surpassing analyst expectations, but its quarterly revenue of $1.76 billion fell short of the estimated $1.80 billion.
  • Terumo has a market cap of $23.56 billion and reported a net margin of 12.09% and a return on equity of 9.19% in its latest earnings release.
  • Five stocks to consider instead of Terumo.

Terumo Corp. (OTCMKTS:TRUMY - Get Free Report) hit a new 52-week low during trading on Thursday . The stock traded as low as $15.95 and last traded at $16.07, with a volume of 18675 shares. The stock had previously closed at $16.46.

Terumo Stock Performance

The company has a market cap of $23.56 billion, a PE ratio of 27.92 and a beta of 0.79. The firm's fifty day moving average is $17.63 and its 200 day moving average is $18.14. The company has a current ratio of 2.64, a quick ratio of 1.53 and a debt-to-equity ratio of 0.07.

Terumo (OTCMKTS:TRUMY - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.20 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.17 by $0.03. Terumo had a net margin of 12.09% and a return on equity of 9.19%. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.80 billion.

Terumo Company Profile

(Get Free Report)

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Terumo Right Now?

Before you consider Terumo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Terumo wasn't on the list.

While Terumo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.